Posted By:
NatureMed Oncology
Category:
Integrative Cancer Support
Our Dr. Kirsten West contributed a write up for the Natural Medicine Journal detailing a clinical trial to assess if the combination of delta tocotrienol and bevacizumab delays the progression of multi-resistant ovarian cancer. Learn how the results show that multiple therapeutic actions and the low toxicity of delta tocotrienol demonstrate synergistic effects with bevacizumab in ovarian cancer.
Study: Delta Tocotrienol and Bevacizumab for Recur...